Shanghai Kaibao Pharmaceutical's actual controller and concerted actor Kaiyi Trading Co. plans to reduce their shareholding by no more than 1%.

Shanghai Kaibao Pharmaceutical (300039.SZ) announced that the company recently received a "Notice of Share Reduction Plan" from its controlling shareholder and actual controller, Ke Yi Shangmao, who is also the consistent actor. Ke Yi Shangmao plans to reduce its shareholding in the company by a total of no more than 10.46 million shares (not exceeding 1% of the company's total share capital) through centralized bidding or block trading within 3 months after 15 trading days from the disclosure of this announcement (from July 23, 2025 to October 22, 2025, except during any window period as stipulated by laws and regulations).